» Articles » PMID: 9184228

Purification of a Tat-associated Kinase Reveals a TFIIH Complex That Modulates HIV-1 Transcription

Overview
Journal EMBO J
Date 1997 May 15
PMID 9184228
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

The Tat protein is a transcriptional activator which is required for efficient human immunodeficiency virus 1 (HIV-1) gene expression Tat stimulates HIV-1 transcriptional elongation by increasing the processivity of RNA polymerase II. To address whether Tat-mediated effects on HIV-1 gene expression are due to modulation in the phosphorylation of the RNA polymerase II C-terminal domain (CTD), we developed a purification protocol to identify cellular kinases that are capable of binding to Tat and hyperphosphorylating the RNA polymerase II CTD. A 600 kDa protein complex with these properties was isolated, and specific components were identified using peptide microsequence analysis. This analysis indicated that proteins comprising the multi-subunit TFIIH complex, in addition to several novel factors, were associated with Tat using both in vitro and in vivo analysis. The Tat-associated kinase bound to the activation domain of Tat, and its ability to hyperphosphorylate RNA polymerase II was markedly stimulated by Tat. Furthermore, the addition of the Tat-associated kinase to in vitro transcription assays stimulated the ability of Tat to activate HIV-1 transcription. These results define a cellular kinase complex whose activity is modulated by Tat to result in activation of HIV-1 trancription.

Citing Articles

Help or Hinder: Protein Host Factors That Impact HIV-1 Replication.

Moezpoor M, Stevenson M Viruses. 2024; 16(8).

PMID: 39205255 PMC: 11360189. DOI: 10.3390/v16081281.


Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells.

Lacombe B, Morel M, Margottin-Goguet F, Ramirez B J Virol. 2016; 90(23):10972-10980.

PMID: 27681137 PMC: 5110165. DOI: 10.1128/JVI.01722-16.


Impact of Tat Genetic Variation on HIV-1 Disease.

Li L, Dahiya S, Kortagere S, Aiamkitsumrit B, Cunningham D, Pirrone V Adv Virol. 2012; 2012:123605.

PMID: 22899925 PMC: 3414192. DOI: 10.1155/2012/123605.


Identification of cellular proteins required for replication of human immunodeficiency virus type 1.

Dziuba N, Ferguson M, OBrien W, Sanchez A, Prussia A, McDonald N AIDS Res Hum Retroviruses. 2012; 28(10):1329-39.

PMID: 22404213 PMC: 3448097. DOI: 10.1089/AID.2011.0358.


9-Aminoacridine inhibition of HIV-1 Tat dependent transcription.

Guendel I, Carpio L, Easley R, Van Duyne R, Coley W, Agbottah E Virol J. 2009; 6:114.

PMID: 19630958 PMC: 2723079. DOI: 10.1186/1743-422X-6-114.


References
1.
Usheva A, Maldonado E, Goldring A, Lu H, Houbavi C, Reinberg D . Specific interaction between the nonphosphorylated form of RNA polymerase II and the TATA-binding protein. Cell. 1992; 69(5):871-81. DOI: 10.1016/0092-8674(92)90297-p. View

2.
Lu H, Zawel L, Fisher L, Egly J, Reinberg D . Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature. 1992; 358(6388):641-5. DOI: 10.1038/358641a0. View

3.
Hodo 3rd H, Blatti S . Purification using polyethylenimine precipitation and low molecular weight subunit analyses of calf thymus and wheat germ DNA-dependent RNA polymerase II. Biochemistry. 1977; 16(11):2334-43. DOI: 10.1021/bi00630a005. View

4.
Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View

5.
Rosen C, Sodroski J, Haseltine W . The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell. 1985; 41(3):813-23. DOI: 10.1016/s0092-8674(85)80062-3. View